November 01, 2013
Otsuka Pharmaceutical Co. Ltd. sued Wockhardt USA LLC in New Jersey federal court Thursday for infringing its patent for Abilify, after the generics maker submitted an abbreviated new drug application for its own version of the schizophrenia and depression drug before the patent expires.